Wang and co-workers developed transferrin-modified liposomes (Tf-PL) for the targeted delivery of acetylcholinesterase (AChE) gene, administered subcutaneously to treat liver cancer xenografts grafted in nude mice [132]. This evidence concerns the gene TF and liver cancer.